Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Karoum

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Biological Psychiatry|February 1, 1984
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in manF Karoum, S Potkin, L W Chuang, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1991
Dorsal hippocampal lesion does not affect dopaminergic indices in the basal gangliaB K Lipska, G E Jaskiw, F Karoum, et al.
Psychiatry Research|April 1, 1982
Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patientsF Karoum, M Linnoila, W Z Potter, et al.
Brain Research|June 13, 1983
Catecholamine content of intracerebral adrenal medulla graftsW J Freed, F Karoum, H E Spoor, et al.
Brain Research|November 26, 1990
Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the ratG E Jaskiw, F Karoum, W J Freed, et al.
Journal of Neurochemistry|July 1, 1979
Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brainF Karoum, H Nasrallah, S Potkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortexC Wahlestedt, F Karoum, G Jaskiw, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 1982
Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjectsA D Mosnaim, F Karoum, A Zeller, et al.
Science (New York, N.Y.)|October 26, 1979
Phenylethylamine in paranoid chronic schizophreniaS G Potkin, F Karoum, L W Chuang, et al.
Archives of General Psychiatry|October 1, 1985
Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatmentA Zametkin, J L Rapoport, D L Murphy, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Biological Psychiatry|February 1, 1984
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in manF Karoum, S Potkin, L W Chuang, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1991
Dorsal hippocampal lesion does not affect dopaminergic indices in the basal gangliaB K Lipska, G E Jaskiw, F Karoum, et al.
Psychiatry Research|April 1, 1982
Fluctuating high urinary phenylethylamine excretion rates in some bipolar affective disorder patientsF Karoum, M Linnoila, W Z Potter, et al.
Brain Research|June 13, 1983
Catecholamine content of intracerebral adrenal medulla graftsW J Freed, F Karoum, H E Spoor, et al.
Brain Research|November 26, 1990
Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the ratG E Jaskiw, F Karoum, W J Freed, et al.
Journal of Neurochemistry|July 1, 1979
Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brainF Karoum, H Nasrallah, S Potkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1991
Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortexC Wahlestedt, F Karoum, G Jaskiw, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 23, 1982
Platelet monoamine oxidase activity and plasma levels of non-catecholic phenylethylamines in insulin-dependent diabetic subjectsA D Mosnaim, F Karoum, A Zeller, et al.
Science (New York, N.Y.)|October 26, 1979
Phenylethylamine in paranoid chronic schizophreniaS G Potkin, F Karoum, L W Chuang, et al.
Archives of General Psychiatry|October 1, 1985
Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatmentA Zametkin, J L Rapoport, D L Murphy, et al.
Pageof 15